Understanding Which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers
pharmafile | November 20, 2013 | Feature | Manufacturing and Production | auto injector, autoinjector, autoinjector innovation, shl autoinjector
SHL’s recent article “Understanding Which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers” was featured in OnDrugDelivery’s October 2013 issue “Prefilled Syringes: The Human Factor”. The article highlights 3 key areas of design – mechanical, industrial and manufacturing. Emphasizing the theme Inspiring Innovation, SHL talks about what device manufacturers should be focusing on when working towards making customized auto injectors, pen injectors and inhalers for their biopharmaceutical partners. The idea behind the article was to share with readers the key areas of design that are required to produce cutting edge products and meet the real needs of end-users. Design areas ranging from human factors engineering to enhanced manufacturing processes designed to maximize production output are discussed as well as trends, opportunities and challenges in the development of auto injectors in particular.
The same 3 design areas mentioned in the article were also part of SHL’s Inspiring Innovation theme at this year’s 2013 PDA Conference in Basel, Switzerland, where different information stations were set up to share with customers how each of these areas are integrated into the design and production of SHL’s devices. This new way of interacting with customers was well received as SHL invited staff from all areas of the company including molding, engineering, mechanical design, industrial design and molding experts. The chance to interact with these staff was really appreciated and generated much interest in not just the devices showcased, but also the manufacturing capabilities and capacities SHL is able to provide for its customers.
Below is a snippet of the article, and the full article can be downloaded HERE, or found online at OnDrugDelivery.
UNDERSTANDING WHICH TYPES OF DESIGN SHOULD BE DRIVING INNOVATION AT DRUG DELIVERY DEVICE SUPPLIERS
As market demand for self-injection devices, such as auto-injectors, continues to grow at a rapid pace, greater emphasis is now being placed on how device companies can innovate. This innovation centres on fulfilling the device needs of biopharmaceutical companies today and helping them bring their combination products to market. Steven Kaufman, Global Marketing Director, SHL Group, writes here about the importance of design innovations that are required to make a drug delivery device by focusing on the areas of mechanical design, industrial design and manufacturing design.
Innovation continues to be a word that is frequently used throughout various industries today. However, when taking into consideration the conservative nature of the biopharmaceutical industry and the device companies that work within that industry, introducing new and innovative technologies can take a significant amount of time to implement. Safety is always a priority and as a result, technologies that are proven on the market are generally preferred. When launched, the DAI disposable auto-injector (shown in Figure 1) set a new standard within the industry. Not only was it easier to use and more intuitive than any other such device on the market, it incorporated some innovative safety solutions. A safety needle shield extended out after the injection was completed to help prevent needle-stick injuries. A larger viewing window gave patients the ability to check the biologic prior to injection and also see the coloured plunger rod when the injection was compete. A patented interlock also helped to ensure that the device would only inject when the patient was ready…
About SHL
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices such as auto injectors and pen injectors. We have over 2,500 staff globally, with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia. SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
Our organization consists of several distinct group companies:
SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
SHL Pharma
Provides final assembly, labeling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries
For additional information visit www.shl-group.com or contact us at info@shl-group.com
SHL Media Contact
Steven R. Kaufman
Marketing Director
+886 32170303
pr@shl-group.com
Related Content
Novartis secures US rights to Adamis’ epinephrine auto injector
Novartis has penned an agreement with Adamis Pharmaceuticals to commercialise and distribute the latter’s epinephrine …
FDA unveils guidelines to help generic medical device versions reach the market
The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of …
SHL brings innovation to Pharmapack Europe 2017
As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on …
